Shi L - Search Results

1

Association between BRAF and RAS mutations, and RET rearrangements and the clinical features of papillary thyroid cancer.

Ming J, Liu Z, Zeng W, Maimaiti Y, Guo Y, Nie X, Chen C, Zhao X, Shi L, Liu C, Huang T. Ming J, et al. Among authors: shi l. Int J Clin Exp Pathol. 2015 Nov 1;8(11):15155-62. eCollection 2015. Int J Clin Exp Pathol. 2015. PMID: 26823860 Free PMC article.

2

[Effect of PC-cell derived growth factor shRNA on estrogen dependent of estrogen receptor negative breast cancer cell lines].

Shi L, Song HP, Liu CP, Huang T. Shi L, et al. Zhonghua Wai Ke Za Zhi. 2007 Apr 1;45(7):483-6. Zhonghua Wai Ke Za Zhi. 2007. PMID: 17686309 Chinese.

3

[Outcome of reoperation for thyroid cancer: clinical analysis of 72 cases].

Shi L, Cheng B, Qu XC, Liu CP, Huang T. Shi L, et al. Zhonghua Wai Ke Za Zhi. 2007 Jul 1;45(13):871-3. Zhonghua Wai Ke Za Zhi. 2007. PMID: 17953827 Chinese.

4

[Operation for differentiated thyroid cancer: a experience of 546 cases].

Li Z, Liu CP, Shi L, Huang T. Li Z, et al. Among authors: shi l. Zhonghua Wai Ke Za Zhi. 2008 Mar 1;46(5):375-7. Zhonghua Wai Ke Za Zhi. 2008. PMID: 18785536 Chinese.

5

[Pathological manifestation and feasibility of conservative breast surgery after effective neoadjuvant chemotherapy for breast cancer].

Liu CP, Shi L, Li Z. Liu CP, et al. Among authors: shi l. Zhonghua Wai Ke Za Zhi. 2008 Sep 15;46(18):1394-6. Zhonghua Wai Ke Za Zhi. 2008. PMID: 19094510 Chinese.

6

Histopathological features of invasion of breast invasive ductal carcinoma and safety of breast-conserving surgery.

Liu C, Pan H, Li Z, Shi L, Huang T. Liu C, et al. Among authors: shi l. J Huazhong Univ Sci Technolog Med Sci. 2009 Feb;29(1):50-2. doi: 10.1007/s11596-009-0110-8. Epub 2009 Feb 18. J Huazhong Univ Sci Technolog Med Sci. 2009. PMID: 19224162

7

Multifocality and total tumor diameter predict central neck lymph node metastases in papillary thyroid microcarcinoma.

Zhao Q, Ming J, Liu C, Shi L, Xu X, Nie X, Huang T. Zhao Q, et al. Among authors: shi l. Ann Surg Oncol. 2013 Mar;20(3):746-52. doi: 10.1245/s10434-012-2654-2. Epub 2012 Sep 13. Ann Surg Oncol. 2013. PMID: 22972508

8

Treatment for papillary thyroid microcarcinoma.

Shi L, Chen JH, Wang ST, Xiong YQ, Huang T. Shi L, et al. Contemp Oncol (Pozn). 2013;17(1):20-3. doi: 10.5114/wo.2013.33769. Epub 2013 Mar 15. Contemp Oncol (Pozn). 2013. PMID: 23788956 Free PMC article.

9

Cytokeratin 19, thyroperoxidase, HBME-1 and galectin-3 in evaluation of aggressive behavior of papillary thyroid carcinoma.

Liu Z, Li X, Shi L, Maimaiti Y, Chen T, Li Z, Wang S, Xiong Y, Guo H, He W, Liu C, Nie X, Zeng W, Huang T. Liu Z, et al. Among authors: shi l. Int J Clin Exp Med. 2014 Aug 15;7(8):2304-8. eCollection 2014. Int J Clin Exp Med. 2014. PMID: 25232425 Free PMC article.

10

Significance of CK19, TPO, and HBME-1 expression for diagnosis of papillary thyroid carcinoma.

Liu Z, Yu P, Xiong Y, Zeng W, Li X, Maiaiti Y, Wang S, Song H, Shi L, Liu C, Cheng B, Zhang B, Ming J, Dong F, Ge H, Nie X, Huang T. Liu Z, et al. Among authors: shi l. Int J Clin Exp Med. 2015 Mar 15;8(3):4369-74. eCollection 2015. Int J Clin Exp Med. 2015. PMID: 26064355 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17,400 results

Search Page

Filters